ICU tube removal showdown: suction vs. pressure

NCT ID NCT05147636

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two methods for removing breathing tubes from ICU patients. One method used suction to clear secretions, while the other used positive pressure to keep the lungs open. The goal was to see which approach helps patients breathe on their own sooner and reduces complications. Over 400 patients took part in this completed trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could point to a safer, more effective way to remove breathing tubes in ICU patients, potentially reducing time on ventilators and complications.
What could go wrong
This is a completed trial comparing two procedures, not a new drug or therapy. Results may not apply to all ICU patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

425 people

The number who actually took part.

Started

Mar 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria Firstly, the decision to extubate must be made by the treating clinicians after having validated that the clinical criteria for weaning are met, namely: according to the international conference consensus on weaning , patients will be considered as ready for an initial SBT as soon as they meet all of the following criteria: * respiratory rate ≤35 breaths per minute, * adequate oxygenation defined as pulse oximetry (SpO2 ≥90%) with a fraction of inspired oxygen (FiO2) ≤0.4 or PaO2/FiO2 ≥150 mmHg with positive end-expiratory pressure ≤8 cm H2O, * hemodynamic stability with no need for vasopressors (or doses ≤0.3 μg/kg/min), * adequate cough, * patient awake with a Richmond Agitation-Sedation Scale between +1 and -2 Patients meeting any of the following criteria will be included in the EXSUPEEP trial: * ICU Hospitalization * Oro-tracheal intubation * Mechanical ventilation for more than 24 h * First extubation procedure during the stay in the including unit * Consent collected from a relative of the patient. Once it has been verified that the patient meets all the eligibility criteria listed above, the patient may be extubated after a successful SBT and after obtaining consent from the patient or family. Exclusion criteria Patients meeting any of the following criteria will be excluded from the EXSUPEEP trial: * Patients receiving ventilation via tracheostomy. * Patients with underlying chronic neuromuscular disease * Patients with severe head injury * Patients with a decision to withhold and/or withdraw life support * Patients not affiliated to or beneficiary of any social security scheme. * Person benefiting from enhanced protection, namely minors, pregnant or nursing women, persons deprived of their liberty by a judicial or administrative decision, persons residing in a healthcare or social establishment, adults under legal protection (safeguard of justice, guardianship or curatorship) * Inclusion in another research project that interferes with the outcomes of the present study * Weanability criteria not met within 72 hours following the signing of consent by the relatives. * Unsuccessful weaning test within 72 hours following the signing of consent by the relatives Patients with personal NIV or continuous positive airway pressure at home will be included if Pressure Support (PS) and/or PEEP used in the ICU unit are different from the usual settings at home. Regarding infection by SARS-CoV-2 or use of endotracheal tubes with subglottic suction, they do not constitute an exclusion criterion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extubation in intensive care unit are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Annecy Genevois

    Annecy, France

  • CH Bourg en Bresse

    Bourg-en-Bresse, France

  • CH Victor Dupouy

    Argenteuil, France

  • CHU Francois Mitterand

    Dijon, France

  • CHU La Miletrie

    Poitiers, France

  • CHU Michallon

    Grenoble, France

  • CHU Orléans

    Orléans, Orléans, France

  • HCL Croix Rousse

    Lyon, France

  • HCL Edouard Herriot

    Lyon, France

  • HCL Lyon Sud

    Lyon, France

  • Hopital Nord

    Saint-Etienne, France